ABCG2 and metastatic neoplasm: Studies in metastatic tumors suggest that ABC transporters presence at the BBB and/or BTB of the primary tumors remain a major contributor of drug resistance and that residual ABC transporters function at the BTB is sufficient to limit drugs’ cytotoxic effects.